arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

HeartBeam, Inc.

BEAT
$0.53 ▲ +0.03 (+5.13%) at close
Healthcare ·Surgical & Medical Instruments & Apparatus ·USSurgical & Medical Instruments & Apparatus
25 Visible periods
20 Metrics
Absolute Benchmarks
Price Chart
18
Health
Poor
Bearish Absolute basis
auto_awesome

Analytical Summary

On an absolute basis, HeartBeam, Inc. shows weak fundamentals, weighed down by Return on Invested Capital and FCF / Net Income. These readings use fixed quality thresholds rather than peer benchmarks, because too few comparable companies are available to rank against.

Market Cap $21.5M
Dividend Yield
Revenue Growth
Op. Margin
ROIC -742.7%
FCF / Share $-0.10
Trailing P/E
Price / Book 34.3x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

25-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Net Income Profit after all expenses
$-4.70M
↑ +14.3%
FCF / Share Free cash flow per share
$-0.10
↑ +35.5%

info Signals below are graded against fixed quality thresholds, not peers — peer ranking needs more comparable companies.

trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Return on Invested CapitalReturn on Invested Capital of -812.1% is weak on an absolute basis (target > 10%)
  • FCF / Net IncomeFCF / Net Income of 0.69x is weak on an absolute basis (target > 1x)

Health Breakdown

Cash Quality
18

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 7 years · 25 quarters